Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | IE. Krop, O Jegede, JE. Grilley-Olson, JD Lauring, SR. Hamilton, JA. Zwiebel, S Li, L Rubinstein, A Doyle, DR. Patton, EP. Mitchell, CL. Arteaga, BA. Conley, D Sims, L Harris, AP. Chen, K Flaherty | ||||||||||||
Title | Results from molecular analysis for therapy choice (MATCH) arm I: Taselisib for PIK3CA-mutated tumors. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/161610/abstract | ||||||||||||
Abstract Text | J Clin Oncol 36, 2018 (suppl; abstr 101) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|